Open an account

Notable Labs

NTBLQ · OTC

$0.00+$0.00 (+0.00%)TodayMarket closed ·
No price history for this range.

About NTBLQ

Notable Labs Ltd. is a clinical-stage platform therapeutics company that develops predictive medicines for patients with cancer. The company is headquartered in Foster City, California and currently employs 16 full-time employees. The company went IPO on 2014-09-30. The firm has created a pipeline of therapeutics that address cancer and immune-inflammatory diseases with the goal of significantly improving patient outcomes and overcoming the limitations of approved treatments. The firm's product candidates are built off of two platform technologies: Vascular Targeting System (VTS), a gene-based technology targeting newly formed blood vessels, and Monocyte Targeting Technology (MTT), an antibody-based technology able to specifically inhibit monocyte migration for immune-inflammatory applications.

Employees
16
Headquarters
Foster City, California
Listed
Sep 30, 2014
Sector
Health Care
Industry
Biotechnology
Website
notablelabs.com

NTBLQ key statistics

Market cap
10
Price-earnings ratio
-0.00
Dividend yield
—
Average volume
2.78K
Volume
286
Open price
$0.00
High today
$0.00
Low today
$0.00
52 Week high
$0.001
52 Week low
$0.00

Notable Labs (NTBLQ) at a glance

Notable Labs (NTBLQ) last traded at $0.00, with a market cap of 10 and a price-to-earnings ratio of 0.00.

Volume so far is 286 shares, below the average of 2.78K shares a day.

Over the past year Notable Labs has ranged from $0.00 to $0.001, and now sits 0% of the way up that range.

Notable Labs met or beat analyst EPS estimates in 0 of the last 8 quarters. In Q2 FY24 it reported -$0.55 per share against an estimate of -$0.4408.

NTBLQ earnings

Earnings per share, reported against the analyst estimate

Didn’t beat the estimate in any of the last 8 quarters.

  1. Q4 FY21: reported -$4.20 per share against an estimate of -$3.15
  2. Q1 FY22: reported -$4.55 per share against an estimate of -$3.89
  3. Q2 FY22: reported -$4.20 per share against an estimate of -$3.79
  4. Q3 FY22: reported -$4.20 per share against an estimate of -$3.97
  5. Q3 FY23: reported -$0.48 per share against an estimate of -$0.4223
  6. Q4 FY23: reported -$5.46 per share against an estimate of -$0.447
  7. Q1 FY24: reported -$0.42 per share against an estimate of -$0.4048
  8. Q2 FY24: reported -$0.55 per share against an estimate of -$0.4408

Similar companies

Companies in the same industry as Notable Labs

Most active stocks

Highest trading volume today

Newly listed

Companies that went public in the past six weeks

Information on this page is provided for informational purposes only and is not a recommendation to buy, sell or hold any security. Investing involves risk, including possible loss of principal. Market data is delayed at least 15 minutes and is provided without warranty. Analyst ratings, price targets and company data come from third-party sources. Past performance does not guarantee future results.